San Ramon, CA, October 10, 2018, – rfxcel, the global leader in track and trace solutions, has released its compliance solution, rfxcel Code Check (rCC), designed to address the specific requirements of the Falsified Medicines Directive (FMD) for pharmaceutical dispensers and hospital pharmacies.
By February 9, 2019 all pharmaceutical dispensers in the European Economic Area (EEA) must be able to electronically verify and decommission prescription medicines before dispensing. rfxcel has applied its fifteen years of traceability expertise and work with pharmacists to develop a simplified, pharmacy specific workflow that addresses the FMD validation process.
Mark Davison, Senior Operations Director Europe, rfxcel, comments: “The Falsified Medicines Directive will soon impact all pharmacies in Europe, and will require dispensers to verify pack features – tamper evidence and data matrix code – prior to dispensing medicines to the patient. This involves an established and ongoing connection to their National Medicines Verification System (NMVS) as well as a scanner capable of reading the data matrix codes printed on medicine packs. As an accredited FMD service provider, rfxcel can facilitate a secure connection to any NMVS, while rfxcel Code Check (rCC) addresses all the functions required under FMD.”
Functionality within rfxcel’s FMD software has been adapted to build a workflow uniquely designed to enable dispensers to manage split packs, aggregation to bag level during preparation of prescriptions in advance, re-commissioning of items from no-shows, and other pharmacy-specific activities impacted by FMD. In addition, rfxcel Code Check (rCC) offers seamless integration with standard data matrix scanners and is available standalone or as an integrated solution with all major pharmacy software providers, providing a range of options and reducing risk.
Mark concludes: “Organisations in the medicine supply chain, including pharmaceutical dispensers, urgently need clarity and support if they are to meet the complex requirements of the FMD by February 2019, especially amidst continued uncertainty around Brexit. More specifically, they need guidance from experienced solution providers with traceability expertise. The FMD is endlessly challenging, but rfxcel Code Check (rCC) builds these requirements into existing pharmacy workflows and offers a great opportunity to improve patient safety and supply chain efficiency.”
Demonstrations of rfxcel Code Check (rCC) will be available to visitors to the Pharmacy Show, 7th & 8th October 2018, Birmingham NEC, UK.